Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02613052 · ClinicalTrials.gov registry record · NA
Agitated Saline, Albumin, or Propofol-albumin Mixture for Enhanced Contrast in TEE Examinations
A NA study of Transesophageal Echocardiography Contrast Agents, sponsored by University of California, San Diego.
- Completed
- Registry status
- NA
- Development phase
- 17
- Enrollment target
- 1
- Study location
NCT02613052 is a NA study of Transesophageal Echocardiography Contrast Agents that has completed, run by University of California, San Diego. The registered enrollment target is 17 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02613052, a NA study of Transesophageal Echocardiography Contrast Agents, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective, randomized, controlled study to determine if albumin and propofol or albumin only will provide superior qualitative contrast enhancement during TEE bubble studies compared to agitated saline. Each patient will receive three randomized bubble studies (agitated saline, albumin, and albumin and propofol) using 10 ml of agitated contrast agent. The albumin and propofol mixture will consist of 7 mL of 5% albumin plus 3 mL of propofol (10 mg/mL). Each patient will undergo qualitative review of all 3 bubble studies by 10 different anesthesiologists and/or cardiologists credentialed to read echocardiographic studies at the time of the surgical procedure, and also with retrospective review of the echo video (\~200 studies). A bicaval view will be obtained to record a 20 beat loop for each bubble study. Hemodynamic variables prior to injection of contrast agent; and 30 seconds, 1 minute and 2 minutes after injection will be monitored and recorded.
Conditions Studied
Interventions
- DRUG normal saline
- DRUG human albumin
- DRUG human albumin and propofol
Study Locations (1)
California
- UC San Diego Sulpizio Cardiovascular Center - La Jolla
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2016-01 |
| Est. Completion | 2017-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02613052
The ClinicalTrials.gov registry entry for NCT02613052 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Transesophageal Echocardiography Contrast Agents appearing as the primary indexed condition, and to 3 interventions - of which normal saline is the first listed.
NCT02613052 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT02613052 about?
NCT02613052 is a clinical study titled "Agitated Saline, Albumin, or Propofol-albumin Mixture for Enhanced Contrast in TEE Examinations". This is a prospective, randomized, controlled study to determine if albumin and propofol or albumin only will provide superior qualitative contrast enhancement during TEE bubble studies compared to agitated saline. Each patient will receive three randomized bubble studies (agitated saline, albumin, ...
What is the current status of trial NCT02613052?
This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2016-01. Estimated completion is 2017-09.
What conditions does trial NCT02613052 study?
This clinical trial studies the following conditions: Transesophageal Echocardiography Contrast Agents.
What interventions are being tested in trial NCT02613052?
The interventions under investigation include: normal saline (DRUG), human albumin (DRUG), human albumin and propofol (DRUG).
Who is sponsoring clinical trial NCT02613052?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02613052 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.